|
|
 |
 |
 |
 |
 |
| Home > Mercy Health Center > Medical Services > Cancer Services > Mercy Women's Center |
 |
 |
 |
Mercy Women's Center
Breast-Dedicated MRI
In January 2002, anticipating a revolution in breast
imaging, Rebecca G. Stough, M.D. launched Oklahoma’s first comprehensive
breast MRI program that incorporated MRI into routine clinical care.

After gaining her initial experience with three
hundred patients undergoing breast MRI using a "breast coil" adaptor on
a hospital body scanner, Dr. Stough switched to the Aurora
breast-dedicated MRI located at Mercy Woman's Center in March 2003.
Since that time, her experience in interpreting over one thousand breast
MRIs per year has brought her into the limelight with this revolutionary
technology.
|




|
|
Dr. Stough now serves on the Medical Advisory Board of
Aurora Imaging, Inc. Where president and CEO Olivia Cheng, has stated,
"Dr. Stough is one of the most experienced doctors in the world reading
bilateral RODEO images...your team is truly outstanding and it's our
honor to partner with you." Dr. Stough has also been a pioneer in the
development of MRI-biopsy techniques, and she spends a good deal of time
in worldwide travels, educating radiologists about breast MRI and MRI-guided
biopsy technique (see our Newsletter Section). Dr. Stough serves as
Clinical Director of Breast MRI of Oklahoma, LLC., while Dr. Carol
O'Dell serves as Assistant Clinical Director, also having interpreted
thousands of dedicated breast MRIs.
|
 |
|
 |
|
Dr. Stough (left) joined RODEO MRI pioneer, Dr.
Steven Harms (right) in a trip to Taiwan, training radiologists in the
interpretation of breast MRI |
|
Dr. Carol O'Dell is a breast-dedicated
radiologist who serves as Assistant Clinical Director of Breast MRI of
Oklahoma |
Indications for
Breast MRI
Newly diagnosed breast cancer – mapping tumor size
and extent to assist with lumpectomy vs. mastectomy decisions; checking
for other areas of cancer in the same breast; screening the opposite
breast for cancer not appreciated on conventional imaging
-
Diagnostic problems not settled by conventional
imaging (multiple or inconclusive findings)
-
Judging the response to neoadjuvant chemotherapy
-
Distinguishing scar from recurrent cancer in
lumpectomy patients
-
Searching for a primary cancer when axillary nodes
are found to harbor malignancy
-
Evaluating for ruptured breast implants
-
Difficult diagnostic problems in patients with
breast implants
-
Pre-operative study to rule out cancer prior to
implants or reduction surgery
-
High Risk Screening (esp. in patients with dense
tissue on mammography)
FOR FREQUENTLY ASKED QUESTIONS (FAQ) ABOUT BREAST
MRI CLICK HERE.
Examples of
Breast MRI Studies
The images below are somewhat limited for online
viewing in that actual interpretations are performed on the computer by
the radiologist who "pages through" hundreds of images, in multiple
directions, or by creating 3-D "hologram". In addition, the images below
are from the "early" days of breast MRI, RODEO™ . For a peek at the
remarkable 3-D images we see today with spiralRODEO™ ,
CLICK HERE.
 |
 |
|
Fig 1
Normal Breast MRI
Breast MRI includes many
variations of the procured images. In this “MIP” version, the thin
slices are re-assembled, creating a 3-D image on the computer that can
be rotated in any direction. Only the gadolinium contrast is seen, so
any worrisome “areas of enhancement” can be viewed from all angles. The
branching white lines in this study (arrow) represent normal blood
vessels. This negative study is a powerful statement that no cancer is
present in this breast.
|
Fig 2
Small invasive cancer
In this subtraction
view, only a thin slice of gadolinium contrast is seen, revealing a
sub-centimeter invasive ductal carcinoma (arrow). A tumor this small
will be invisible on mammography if it is surrounded by dense breast
tissue. The advantage to finding cancer smaller than 1.0 cm is a cure
rate in excess of 90% if lymph nodes are clear, along with infrequent
use of chemotherapy. |

Fig 3 (left)
Ductal carcinoma in Situ (DCIS)
While
often called “early” breast cancer, DCIS can still spread throughout the
ductal system and be more difficult to eradicate from the breast than
many invasive cancers. Calcium is best detected on mammography, and it
often leads to DCIS, but the extent of disease is frequently
underestimated. In addition, many DCIS lesions do not develop calcium at
all. Once again, Breast MRI is proving to be a very helpful adjunct in
the detection of DCIS. In this patient’s breast, the DCIS forms both
patchy and linear enhancements, and the problem proved to be much more
extensive than believed from mammography alone.
|
 |
 |
|
Fig 4a (left) and 4b (right)
Axillary Adenopathy
with Unknown Primary
This patient presented with an enlarged lymph node
in her axilla (left: arrow) that proved to harbor metastatic cancer
cells. While breast is the most likely site of origin, it is not always
true, and this patient’s mammograms were normal. In years past, women
presenting with malignant axillary nodes would undergo “blind”
mastectomy, and it was not unusual for the breast to be normal on
pathology exam (or, to find a small cancer that could have been handled
easily with lumpectomy). Today, with breast MRI, one can see how clearly
the subtraction view (right) shows a multifocal cancer (arrows) that was
invisible on routine imaging studies.
|
 |
|
(left to right) Fig 5a, Fig 5b, and Fig 5c
Extent of
Cancer Grossly Underestimated by Mammography and Ultrasound.
Mammograms
were low density in this patient, so when “invasive ductal carcinoma”
was diagnosed from a solitary mass lesion, mammograms were felt to have
accurately mapped the tumor pre-operatively. Ultrasound further
confirmed a small, solitary tumor, so lumpectomy was advised and
performed on the left breast. However, the surgeon was unable to obtain
clear margins around the tumor after several attempts, so the procedure
was ended, and breast MRI performed. In Figure 5a, one can see the large
lumpectomy cavity (small arrows outline the bright fluid in the cavity),
while an extensive area of residual cancer remains (large arrow). This
residual cancer is best seen in the subtraction view (Figure 5b) as it
extends throughout a large area (arrow) of the breast. However, the
opposite breast (Figure 5c) had several areas of suspicious enhancement
as well (arrow shows one example in the upper outer quadrant). Final
diagnosis after bilateral mastectomy: extensive infiltrating lobular
carcinoma, involving multiple quadrants in both breasts. |
|
|
|